APLN and malignant colon neoplasm: Regarding combination therapies assessed in in-vivo, overexpressed APLN was reported to promote the maturation of the cancer vasculature and subsequently enhanced its immune therapy efficiency in orthotopic colon cancer models (Kidoya et al., 2012).